1. Dollo G, Chevanne F, Le Corre P, Chemtob C, Le Verge R (1999) Bioavailability of phloroglucinol in man. J Pharm Belg 54:75–82
2. Mainguet P (1969) A new antispasmodic drug in the treatment of biliary and intestinal diseases: a clinical test. Acta Gastroenterol Belg 32:771–777
3. Foti A, Penazzo S, Volpe L (1971) Use of a new spasmolytic agent (Spasmex) in obstetrics. Minerva Ginecol 23:480–488
4. HAS (Haute autorité de santé) (2017) Commision de la Transparence, Avis 27 septembre 2017 phloroglucinol/triméthylphloroglucinol. In: Dir. l’Evaluation Médicale Econ. Santé Publique
https://www.has-sante.fr/portail/upload/docs/evamed/CT-16331_SPASFON_PIS_RI_Avis1_CT16331.pdf
. Accessed 27 Oct 2018
5. Cahen R (1962) Phloroglucinol: a pharmacological reevaluation. Smooth muscle relaxing properties. Arch Int Pharmacodyn Ther 138:311–319